76 related articles for article (PubMed ID: 25348313)
1. Assessment of the HPV DNA methylation status in cervical lesions.
Kalantari M; Bernard HU
Methods Mol Biol; 2015; 1249():267-80. PubMed ID: 25348313
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
3. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia.
Kalantari M; Calleja-Macias IE; Tewari D; Hagmar B; Lie K; Barrera-Saldana HA; Wiley DJ; Bernard HU
J Virol; 2004 Dec; 78(23):12762-72. PubMed ID: 15542628
[TBL] [Abstract][Full Text] [Related]
4. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia.
Turan T; Kalantari M; Cuschieri K; Cubie HA; Skomedal H; Bernard HU
Virology; 2007 Apr; 361(1):185-93. PubMed ID: 17175003
[TBL] [Abstract][Full Text] [Related]
5. The presence of methylation of the p16INK4A gene and human papillomavirus in high-grade cervical squamous intraepithelial lesions.
Furtado YL; Almeida G; Lattario F; Silva KS; Maldonado P; Silveira FA; do Val IC; Fonseca R; Carvalho Mda G
Diagn Mol Pathol; 2010 Mar; 19(1):15-9. PubMed ID: 20186007
[TBL] [Abstract][Full Text] [Related]
6. Investigation of genomic methylation status using methylation-specific and bisulfite sequencing polymerase chain reaction.
Carless M
Methods Mol Biol; 2009; 523():217-34. PubMed ID: 19381936
[TBL] [Abstract][Full Text] [Related]
7. Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia.
Murakami I; Fujii T; Dan K; Saito M; Ohno A; Iwata T; Aoki D
J Clin Virol; 2013 Sep; 58(1):149-54. PubMed ID: 23871162
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation.
Badal S; Badal V; Calleja-Macias IE; Kalantari M; Chuang LS; Li BF; Bernard HU
Virology; 2004 Jul; 324(2):483-92. PubMed ID: 15207633
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
10. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
12. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative polymerase chain reaction-based methods for DNA methylation analyses.
Wong IH
Methods Mol Biol; 2006; 336():33-43. PubMed ID: 16916251
[TBL] [Abstract][Full Text] [Related]
15. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
16. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women.
Song YS; Kee SH; Kim JW; Park NH; Kang SB; Chang WH; Lee HP
Gynecol Oncol; 1997 Aug; 66(2):275-81. PubMed ID: 9264576
[TBL] [Abstract][Full Text] [Related]
17. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
[TBL] [Abstract][Full Text] [Related]
18. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women.
Tornesello ML; Buonaguro L; Izzo S; Lopez G; Vega X; Maldonado Reyes CF; Buonaguro FM
J Med Virol; 2008 Nov; 80(11):1959-65. PubMed ID: 18814248
[TBL] [Abstract][Full Text] [Related]
20. Detection of high-risk subtypes of human papillomavirus in cervical swabs: routine use of the Digene Hybrid Capture assay and polymerase chain reaction analysis.
Brennan MM; Lambkin HA; Sheehan CD; Ryan DD; O'Connor TC; Kealy WF
Br J Biomed Sci; 2001; 58(1):24-9. PubMed ID: 11284220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
